Education
About Us
Working with TipRanks
Follow Us
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
NYMXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.40
Previous CloseN/A
Volume2.20K
Average Volume (3M)13.41K
Market Cap
$12.81M
Enterprise ValueN/A
Total Cash (Recent Filing)$70.00K
Total Debt (Recent Filing)$750.00K
Price to Earnings (P/E)―
Beta-421.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding93,540,140
10 Day Avg. Volume10,214
30 Day Avg. Volume13,406
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nymox Pharmaceutical News
---
Ownership Overview
―
Insiders
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NYMXF FAQ
What was Nymox Pharmaceutical’s price range in the past 12 months?
Nymox Pharmaceutical lowest stock price was <$0.01 and its highest was $1.40 in the past 12 months.
What is Nymox Pharmaceutical’s market cap?
Nymox Pharmaceutical’s market cap is $12.81M.
When is Nymox Pharmaceutical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nymox Pharmaceutical’s earnings last quarter?
Currently, no data Available
Is Nymox Pharmaceutical overvalued?
According to Wall Street analysts Nymox Pharmaceutical’s price is currently Overvalued.
Does Nymox Pharmaceutical pay dividends?
Nymox Pharmaceutical does not currently pay dividends.
What is Nymox Pharmaceutical’s EPS estimate?
Nymox Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nymox Pharmaceutical have?
Nymox Pharmaceutical has 93,540,140 shares outstanding.
What happened to Nymox Pharmaceutical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nymox Pharmaceutical?
Currently, no hedge funds are holding shares in NYMXF
---
Company Description
Nymox Pharmaceutical
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.
---
Technical Analysis
Cyclacel Pharmaceuticals
―
Alterity Therapeutics
―
SCYNEXIS
―
Brainstorm Cell Therapeutics
―
ESSA Pharma
―
---